Format

Send to

Choose Destination
J Clin Oncol. 2006 Sep 20;24(27):4517-20.

Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.

Author information

1
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
PMID:
16983123
DOI:
10.1200/JCO.2006.06.6126
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center